Have a personal or library account? Click to login
An update on the GLOB blood group system and collection Cover

An update on the GLOB blood group system and collection

Paid access
|Dec 2019

References

  1. Sanger R. An association between the P and Jay systems of blood groups. Nature 1955;176:1163–4.10.1038/1761163a0
  2. Matson GA, Swanson J, Noades J, Sanger R, Race RR. A new antigen and antibody belonging to the P blood group system. Amer J Hum Genet 1959;11:26–34.
  3. Naiki M, Marcus DM. Human erythrocyte P and Pk blood group antigens: identification as glycosphingolipids. Biochem Biophys Res Commun 1974;60:1105–11.10.1016/0006-291X(74)90426-4
  4. Hellberg Å, Poole J, Olsson ML. Molecular basis of the globoside-deficient P(k) blood group phenotype. Identification of four inactivating mutations in the UDP-N-acetylgalactosamine: globotriaosylceramide 3-beta-N-acetylgalactosaminyltransferase gene. J Biol Chem 2002;277: 29455–9.10.1074/jbc.M20304720012023287
  5. Olsson ML, Peyrard T, Hult AK, et al. PX2: a new blood group antigen with implications for transfusion recommendations in P1k and P2k individuals (abstract). Vox Sang 2011;101 (Suppl 1):53.
  6. Amado M, Almeida R, Carneiro F, et al. A family of human beta3-galactosyltransferases. Characterization of four members of a UDP-galactose:beta-N-acetyl-glucosamine/beta-N-acetyl-galactosamine beta-1,3-galactosyltransferase family. J Biol Chem 1998;273:12770–8.10.1074/jbc.273.21.127709582303
  7. Okajima T, Nakamura Y, Uchikawa M, et al. Expression cloning of human globoside synthase cDNAs. Identification of beta3Gal-T3 as UDP-N-acetylgalactosamine:globotriaosylceramide beta1,3-N-acetylgalactosaminyltransferase. J Biol Chem 2000;275:40498–503.10.1074/jbc.M00690220010993897
  8. Hellberg Å, Ringressi A, Yahalom V, Säfwenberg J, Reid ME, Olsson ML. Genetic heterogeneity at the glycosyltransferase loci underlying the GLOB blood group system and collection. Br J Haematol 2004;125:528–36.10.1111/j.1365-2141.2004.04930.x15142124
  9. Westman JS, Hellberg Å, Peyrard T, Hustinx H, Thuresson B, Olsson ML. Molecular dissection of rare phenotypes in the P1PK and GLOB histo-blood group systems with novel genetic markers (abstract). Transfusion 2011;51(Suppl 3):24A.
  10. Kundu SK, Steane SM, Bloom JE, Marcus DM. Abnormal glycolipid composition of erythrocytes with a weak P antigen. Vox Sang 1978;35:160–7.10.1111/j.1423-0410.1978.tb02916.x676244
  11. Kundu SK, Evans A, Rizvi J, Glidden H, Marcus DM. A new Pk phenotype in the P blood group system. J Immunogenet 1980;7:431–9.10.1111/j.1744-313X.1980.tb00738.x
  12. Nakajima H, Yokota T. Two Japanese families with Pk members. Vox Sang 1977;32:56–8.10.1111/j.1423-0410.1977.tb00604.x841964
  13. Race RR, Sanger R. Blood groups in man. Oxford, UK: Blackwell Scientific Publications, 1975.
  14. Kortekangas AE, Kaarsalo E, Melartin L, et al. The red cell antigen Pk and its relationship to the P system: the evidence of three more Pk families. Vox Sang 1965;10:385–404.10.1159/000465021
  15. Fletcher KS, Bremer EG, Schwarting GA. P blood group regulation of glycosphingolipid levels in human erythrocytes. J Biol Chem 1979;254:11196–8.10.1016/S0021-9258(19)86468-2
  16. Cantin G, Lyonnais J. Anti-PP1Pk and early abortion. Transfusion 1983;23:350–1.10.1046/j.1537-2995.1983.23483276877.x
  17. Lindström K, Von Dem Borne AE, Breimer ME, et al. Glycosphingolipid expression in spontaneously aborted fetuses and placenta from blood group p women. Evidence for placenta being the primary target for anti-Tja-antibodies. Glycoconj J 1992;9:325–9.10.1007/BF00731093
  18. Fernández-Jiménez MC, Jiménez-Marco MT, Hernández D, González A, Omeñaca F, de la Cámara C. Treatment with plasmapheresis and intravenous immunoglobulin in pregnancies complicated with anti-PP1Pk or anti-K immunization: a report of two patients. Vox Sang 2001;80: 117–20.10.1046/j.1423-0410.2001.00021.x
  19. Yang Z, Bergström J, Karlsson KA. Glycoproteins with Gal alpha 4Gal are absent from human erythrocyte membranes, indicating that glycolipids are the sole carriers of blood group P activities. J Biol Chem 1994;269:14620–4.10.1016/S0021-9258(17)36669-3
  20. Keusch JJ, Manzella SM, Nyame KA, Cummings RD, Baenziger JU. Cloning of Gb3 synthase, the key enzyme in globo-series glycosphingolipid synthesis, predicts a family of alpha 1, 4-glycosyltransferases conserved in plants, insects, and mammals. J Biol Chem 2000;275:25315–21.10.1074/jbc.M002630200
  21. Fujii Y, Numata S, Nakamura Y, et al. Murine glycosyltransferases responsible for the expression of globoseries glycolipids: cDNA structures, mRNA expression, and distribution of their products. Glycobiology 2005;15:1257–67.10.1093/glycob/cwj015
  22. Zoja C, Corna D, Farina C, et al. Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1. J Lab Clin Med 1992;120:229–38.
  23. Issitt PD, Anstee DJ. Applied blood group serology. 4th ed. Miami, FL: Montgomery Scientific Publications, 1998.
  24. Svennerholm E, Svennerholm L. The separation of neutral blood-serum glycolipids by thin-layer chromatography. Biochim Biophys Acta 1963;70:432–41.10.1016/0006-3002(63)90773-X
  25. Zumbrun SD, Hanson L, Sinclair JF, et al. Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide. Infect Immun 2010;78:4488–99.10.1128/IAI.00620-10297636420732996
  26. von dem Borne AE, Bos MJ, Joustra-Maas N, et al. A murine monoclonal IgM antibody specific for blood group P antigen (globoside). Br J Haematol 1986;63:35–46.10.1111/j.1365-2141.1986.tb07492.x2423110
  27. Shevinsky LH, Knowles BB, Damjanov I, Solter D. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 1982;30:697–705.10.1016/0092-8674(82)90274-4
  28. Cooling LL, Koerner TA, Naides SJ. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect Dis 1995;172:1198–205.10.1093/infdis/172.5.1198
  29. Song Y, Withers DA, Hakomori S. Globoside-dependent adhesion of human embryonal carcinoma cells, based on carbohydrate-carbohydrate interaction, initiates signal transduction and induces enhanced activity of transcription factors AP1 and CREB. J Biol Chem 1998;273:2517–25.10.1074/jbc.273.5.2517
  30. Brown KE, Hibbs JR, Gallinella G, et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994;330:1192–6.10.1056/NEJM199404283301704
  31. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004; 350:586–97.10.1056/NEJMra030840
  32. de Jong EP, Walther FJ, Kroes AC, Oepkes D. Parvovirus B19 infection in pregnancy: new insights and management. Prenat Diagn 2011;31:419–25.10.1002/pd.2714
  33. Heddle NM. Acute paroxysmal cold hemoglobinuria. Transfus Med Rev 1989;3:219–29.10.1016/S0887-7963(89)70082-1
  34. Moulds JM, Moulds JJ. Blood group associations with parasites, bacteria, and viruses. Transfus Med Rev 2000;14:302–11.10.1053/tmrv.2000.1622711055075
  35. Ziegler T, Jacobsohn N, Fünfstück R. Correlation between blood group phenotype and virulence properties of Escherichia coliin patients with chronic urinary tract infection. Int J Antimicrob Agents 2004;24(Suppl 1):S70–5.10.1016/j.ijantimicag.2004.03.00215364312
  36. Tippett P, Sanger R, Race RR, Swanson J, Busch S. An agglutinin associated with the P and the ABO blood group systems. Vox Sang 1965;10:269–80.10.1111/j.1423-0410.1965.tb01390.x14332927
  37. Gillard BK, Jones MA, Marcus DM. Glycosphingolipids of human umbilical vein endothelial cells and smooth muscle cells. Arch Biochem Biophys 1987;256:435–45.10.1016/0003-9861(87)90600-X
  38. Stroud MR, Stapleton AE, Levery SB. The P histo-blood group-related glycosphingolipid sialosyl galactosyl globoside as a preferred binding receptor for uropathogenic Escherichia coli:isolation and structural characterization from human kidney. Biochemistry 1998;37:17420–8.10.1021/bi9814639
  39. Cooling LL, Zhang D, Koerner TA. Human platelets express gangliosides with LKE activity and ABH blood group activity. Transfusion 2001;41:504–16.10.1046/j.1537-2995.2001.41040504.x
  40. Cooling LL, Kelly K. Inverse expression of P(k) and Luke blood group antigens on human RBCs. Transfusion 2001;41: 898–907.10.1046/j.1537-2995.2001.41070898.x
  41. Kannagi R, Fukuda MN, Hakomori S. A new glycolipid antigen isolated from human erythrocyte membranes reacting with antibodies directed to globo-N-tetraosylceramide (globoside). J Biol Chem 1982;257:4438–42.10.1016/S0021-9258(18)34741-0
  42. Thorn JJ, Levery SB, Salyan ME, et al. Structural characterization of x2 glycosphingolipid, its extended form, and its sialosyl derivatives: accumulation associated with the rare blood group p phenotype. Biochemistry 1992;31:6509–17.10.1021/bi00143a0221378756
  43. Storry JR, Castilho L, Daniels G, et al. International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report. Vox Sang 2011;101:77–82.10.1111/j.1423-0410.2010.01462.x549784821401621
DOI: https://doi.org/10.21307/immunohematology-2019-119 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 19 - 24
Published on: Dec 1, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Å. Hellberg, J.S. Westman, M.L. Olsson, published by American National Red Cross
This work is licensed under the Creative Commons License.